These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4391894)

  • 21. Neuro-muscular depressant action of pindolol in comparison with propranolol and procaine.
    Nirmala G; Brahmayya Sastry P
    Arch Int Pharmacodyn Ther; 1979 Apr; 238(2):196-205. PubMed ID: 475508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
    Levy JV
    J Clin Pharmacol New Drugs; 1971; 11(4):249-60. PubMed ID: 4397374
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of three beta-adrenoceptor blocking drugs on isolated preparations of skeletal and cardiac muscle.
    Harry JD; Linden RJ; Snow HM
    Br J Pharmacol; 1974 Oct; 52(2):275-81. PubMed ID: 4155991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the myocardial depressant effect of KL 255: a beta adrenergic receptor antagonist.
    Pendleton RG; Petta JM; Hahn RA
    Arch Int Pharmacodyn Ther; 1970 Sep; 187(1):75-87. PubMed ID: 4394700
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of propranolol, oxprenolol, and practolol on denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br Heart J; 1971 Jul; 33(4):614-5. PubMed ID: 4397631
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pindolol. New beta blocking agent. Effect on cardiac chronotropism and ionotropism and comparison of its activity with propranolol].
    Aquaro G; Baduini G; Pavia M; Poletti T
    Minerva Cardioangiol; 1972 Jun; 20(6):324-9. PubMed ID: 4402731
    [No Abstract]   [Full Text] [Related]  

  • 27. Antagonism by beta-adrenoceptor blocking agents of the antianaphylactic effect of isoprenaline.
    Assem ES; Schild HO
    Br J Pharmacol; 1971 Aug; 42(4):620-30. PubMed ID: 4107257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sites of action of SKF 525-A in nerve and muscle.
    Suarez-Kurtz G; Bianchi CP
    J Pharmacol Exp Ther; 1970 Mar; 172(1):33-43. PubMed ID: 4984669
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of dopamine and other catecholamines on neuromuscular transmission.
    Blum K
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):297-306. PubMed ID: 4326551
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of some beta adrenergic blocking agents on the central and peripheral actions of tremorine and oxotremorine.
    Leslie GB; Hayman DG; Ireson JD; Smith S
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):108-11. PubMed ID: 4402325
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of a new beta-adrenergic receptor blocking agent, alprenolol, andts optical isomers.
    Belliveau RE; Covino BG
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):341-9. PubMed ID: 4390664
    [No Abstract]   [Full Text] [Related]  

  • 32. Adrenergic blocking properties of MJ 1999 and butoxamine on cardiac and vascular beta-receptors.
    Wilkenfeld BE; Levy B
    Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):218-32. PubMed ID: 5709786
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of adrenergic neurone blockade in the hypotensive action of propranolol.
    Eliash S; Weinstock M
    Br J Pharmacol; 1971 Oct; 43(2):287-94. PubMed ID: 4400571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interrelationships between the contractile effects of metabolic substrates, beta-adrenergic blocking agents and endogenous catecholamine depletion on isolated rat atria.
    Gimeno MF; Clusella JA; Gimeno AL
    Experientia; 1970 Aug; 26(8):860-3. PubMed ID: 4393785
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist.
    Ablad B; Brogård M; Ek L
    Acta Pharmacol Toxicol (Copenh); 1967; 25():9-40. PubMed ID: 6072577
    [No Abstract]   [Full Text] [Related]  

  • 36. Potentiation of the effects of catecholamines by alpha- and their antagonism by beta-adrenergic blocking agents on the guinea-pig isolated trachea in vitro and on the guinea-pig lungs in vivo.
    Guirgis HM
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):31-42. PubMed ID: 4390920
    [No Abstract]   [Full Text] [Related]  

  • 37. Hemodynamic effects of beta adrenergic receptor stimulant and blockade. Hemodynamic effects of isoproterenol after propranolol.
    Fukuta I
    Nagoya J Med Sci; 1972 Feb; 34(3):199-212. PubMed ID: 4400755
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of new guanidine derivatives on ganglionic and neuromuscular transmission.
    Kadzielawa K; Gumulka W
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):297-309. PubMed ID: 4294771
    [No Abstract]   [Full Text] [Related]  

  • 39. The inhibitory action of dopamine on the rat anterior tibialis muscle preparation.
    Capetola R; Ferko AP; Calesnick B
    Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):107-13. PubMed ID: 4824885
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of a few -sympatholytics (propranolol, C.39'089-Ba, H56-28 and Ko 592) on serum cholinesterase of rats].
    Marmo E
    Jpn J Pharmacol; 1971 Jun; 21(3):421-3. PubMed ID: 4397670
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.